Dermatology NewsAntibody mix may prevent COVID symptoms in some asymptomatic peopleFebruary 3, 2022COVID-19 UpdatesInfectious Diseases
Dermatology NewsDryness, conjunctival telangiectasia among ocular symptoms common in rosaceaFebruary 2, 2022Rosacea
Dermatology NewsWhat docs don’t know about the Disabilities Act can hurt them and patientsFebruary 1, 2022Business of MedicinePractice Management
Dermatology NewsOmicron subvariant 1.5 times more contagious than OmicronFebruary 1, 2022COVID-19 Updates
Dermatology NewsA dermatologist-led model for CVD prevention in psoriasis may be feasibleFebruary 1, 2022PsoriasisPsoriatic Arthritis
Dermatology NewsNew AAD guidelines eye comorbidities in adults with atopic dermatitisJanuary 28, 2022Atopic DermatitisMixed Topics
Dermatology NewsLong COVID is real, and many real questions remainJanuary 28, 2022COVID-19 UpdatesLong COVID
Dermatology NewsOmicron survives longer on plastic, skin than other COVID variantsJanuary 26, 2022COVID-19 UpdatesInfectious Diseases
Dermatology NewsPresence of autoantibodies most predictive of long COVID in studyJanuary 26, 2022COVID-19 UpdatesInfectious DiseasesLong COVID
Dermatology NewsMore frequent secukinumab dosing found to benefit overweight psoriasis patientsJanuary 26, 2022PsoriasisPsoriatic ArthritisMixed Topics
Dermatology News‘Post-truth era’ hurts COVID-19 response, trust in scienceJanuary 24, 2022COVID-19 Updates
Dermatology NewsPhase 2 studies of novel JAK1 inhibitor for HS show promiseJanuary 21, 2022Medical Dermatology
Dermatology NewsRituximab and COVID-19 vaccines: Studies begin to answer key questionsJanuary 21, 2022COVID-19 UpdatesAutoimmune Diseases
Dermatology NewsAntimicrobial resistance linked to 1.2 million global deaths in 2019January 21, 2022Infectious Diseases
